Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Clinical Trial

Randomized Controlled Trial

Research Support, U.S. Gov't, P.H.S.

Comparative Study

Clinical Trial, Phase II

Case Reports

Observational Study

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2025

2024

2022

2020

2017

2015

2014

2013

2010

2009

2007

2005

2003

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""11-beta-Hydroxysteroid Dehydrogenase Type 2""[mesh_terms]

26 Results

Searching titles within these results

Hypertension and the cortisol-cortisone shuttle.

Marcus Quinkler, Paul M Stewart

The Journal of clinical endocrinology and metabolism 2003;88(6):2384-92

Full Text

Abstract

Why are mineralocorticoid receptors so nonselective?

John W Funder

Current hypertension reports 2007;9(2):112-6

Full Text

Abstract

11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.

P C White

The American journal of the medical sciences 2002;322(6):308-15

Full Text

Abstract

Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation.

Patrick W F Hadoke, Tiina Kipari, Jonathan R Seckl, Karen E Chapman

Current atherosclerosis reports 2013;15(5):320

Free Full Text

Abstract

Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.

David J Torpy, Nancy Mullen, Ioannis Ilias, Lynnette K Nieman

Annals of the New York Academy of Sciences 2002;970():134-44

Full Text

Abstract

Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase.

P C White, A K Agarwal, B S Nunez, G Giacchetti, F Mantero, P M Stewart

Endocrine research 2001;26(4):771-80

Full Text

Abstract

Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia.

Afroze Abbas, Marian Schini, Gemma Ainsworth, Sarah R Brown, Jamie Oughton, Rachel K Crowley, Mark S Cooper, Rebecca J Fairclough, Richard Eastell, Paul M Stewart

The Journal of clinical endocrinology and metabolism 2022;107(7):2026-2035

Free Full Text

Abstract

Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess.

B I Cerame, M I New

Journal of pediatric endocrinology & metabolism : JPEM 2001;13(9):1537-47

Full Text

Abstract

The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.

Akitomo Yokokawa, Toru Takasaka, Hiromi Shibasaki, Yasuji Kasuya, Soko Kawashima, Akira Yamada, Takashi Furuta

Steroids 2013;77(12):1291-7

Full Text

Abstract

Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 Activity in Kidney Disease Disrupts 11-Oxygenated Androgen Biosynthesis.

Maria Tomkins, Rowan S Hardy, Conall O'Seaghdha, Fozia Shaheen, Mark Denton, Colm Magee, Imken Oestlund, Michael S Sagmeister, Michael W O'Reilly, Wiebke Arlt, Karl-Heinz Storbeck, Mark Sherlock, Marie McIlroy, Leanne Cussen, Angela E Taylor, Tara McDonnell, Lorna C Gilligan, Lorraine Harper, Jacky L Snoep, Declan de Freitas, Peter Conlon

The Journal of clinical endocrinology and metabolism 2025;110(6):1701-1715

Free Full Text

Abstract

Apparent mineralocorticoid excess.

John W Funder

The Journal of steroid biochemistry and molecular biology 2017;165(Pt A):151-153

Full Text

Abstract

Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides.

Tracy A Williams, Paolo Mulatero, Fabiana Filigheddu, Chiara Troffa, Alberto Milan, Giuseppe Argiolas, Paolo Pinna Parpaglia, Franco Veglio, Nicola Glorioso

Kidney international 2005;67(2):631-7

Free Full Text

Abstract

Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist.

Javaid Iqbal, Ruth Andrew, Nicholas L Cruden, Christopher J Kenyon, Katherine A Hughes, David E Newby, Patrick W F Hadoke, Brian R Walker

The Journal of clinical endocrinology and metabolism 2014;99(3):915-22

Free Full Text

Abstract

Low-dose dexamethasone as a treatment for women with heavy menstrual bleeding: protocol for response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM).

H O D Critchley, B R Walker, S Semple, J P Iredale, P T K Saunders, S G Hillier, M Madhra, A Douglas, C J Weir, P Warner, C H Hansen

BMJ open 2015;5(1):e006837

Free Full Text

Abstract

Apparent mineralocorticoid excess in Israel: a case series and literature review.

Raphael Halevy, Rozan Mokatern, Efrat Ben Shalom, Asaf Lebel, Daniela Magen, Yoav Zehavi

European journal of endocrinology 2024;190(5):347-353

Full Text

Abstract

Results: 1 – 15 / 26

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""11-beta-Hydroxysteroid Dehydrogenase Type 2""[mesh_terms]

Hypertension and the cortisol-cortisone shuttle.

Why are mineralocorticoid receptors so nonselective?

11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.

Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation.

Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.

Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase.

Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia.

Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess.

The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.

Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 Activity in Kidney Disease Disrupts 11-Oxygenated Androgen Biosynthesis.

Apparent mineralocorticoid excess.

Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides.

Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist.

Low-dose dexamethasone as a treatment for women with heavy menstrual bleeding: protocol for response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM).

Apparent mineralocorticoid excess in Israel: a case series and literature review.

Results for

""11-beta-Hydroxysteroid Dehydrogenase Type 2""[mesh_terms]